icons-011.png

Program for Analytics and Compliance Education

(P.A.C.E.)

Now is the time for regenerative medicine clinics, related medical service providers, and industry to comply with current regulations concerning Human Cells, Tissues and Cellular and Tissue-based Products (HCT/Ps). 

Across the United States, targeted enforcement of federal regulatory standards for the field of regenerative medicine has intensified. 

The US FDA, state authorities, professional licensing bodies, and other oversight agencies are all involved. Tech giants are now using their powerful search algorithms to identify  language used to promote the  stem cell  industry, and they too have tightened their own rules relating to the marketing tools used by those who practice regenerative medicine. 

Figure 1. Aggregate Target

Regenerative Outcomes’ PACE program helps clinics, practitioners, and industry navigate regulatory requirements and enforcement by highlighting potential non-compliant marketing practices intended for the public.

 

Regenerative Outcomes developed PACE using heuristic models inspired by companies and regulatory bodies like the FDA, Google, the Federation of State Medical Boards, International Society for Stem Cell Research, AARP and more. 

 

Take action now by contacting Regenerative Outcomes to learn how the PACE program can help your company or practice improve its compliance posture with Federal and other authorities.

 

The call you make today could help determine the future of your vital and life-changing work, and reduce an enforcement risk that could dilute both your potential - and  your bottom line.

Figure 1. Aggregate Target

PACEDOUGREVISED201111_Page_01
PACEDOUGREVISED201111_Page_03
PACEDOUGREVISED201111_Page_04
PACEDOUGREVISED201111_Page_05
PACEDOUGREVISED201111_Page_07
PACEDOUGREVISED201111_Page_08
PACEDOUGREVISED201111_Page_09
PACEDOUGREVISED201111_Page_10
PACEDOUGREVISED201111_Page_11
PACEDOUGREVISED201111_Page_12
PACEDOUGREVISED201111_Page_13
PACEDOUGREVISED201111_Page_14
PACEDOUGREVISED201111_Page_15
PACEDOUGREVISED201111_Page_16
PACEDOUGREVISED201111_Page_17
PACEDOUGREVISED201111_Page_18
PACEDOUGREVISED201111_Page_19
PACEDOUGREVISED201111_Page_38
PACEDOUGREVISED201111_Page_21
PACEDOUGREVISED201111_Page_22
PACEDOUGREVISED201111_Page_23
PACEDOUGREVISED201111_Page_24
PACEDOUGREVISED201111_Page_25
PACEDOUGREVISED201111_Page_26
PACEDOUGREVISED201111_Page_27
PACEDOUGREVISED201111_Page_28
PACEDOUGREVISED201111_Page_29
PACEDOUGREVISED201111_Page_30
PACEDOUGREVISED201111_Page_31
PACEDOUGREVISED201111_Page_32
PACEDOUGREVISED201111_Page_33
PACEDOUGREVISED201111_Page_34
PACEDOUGREVISED201111_Page_35
PACEDOUGREVISED201111_Page_36
PACEDOUGREVISED201111_Page_37
PACEDOUGREVISED201111_Page_38
PACEDOUGREVISED201111_Page_39
PACEDOUGREVISED201111_Page_40

info@regenerativeoutcomes.com

+1 (855) FDA-RMAT

P.O. Box 40211, Nashville, TN 37204

© 2020 Regenerative Outcomes, LLC.   All Rights Reserved.